<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/50E55759-0E37-48B7-9DCA-BB9F3CCC364A"><gtr:id>50E55759-0E37-48B7-9DCA-BB9F3CCC364A</gtr:id><gtr:name>Joseph Fourier University</gtr:name><gtr:address><gtr:line1>CS40700</gtr:line1><gtr:postCode>F-38058</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/50E55759-0E37-48B7-9DCA-BB9F3CCC364A"><gtr:id>50E55759-0E37-48B7-9DCA-BB9F3CCC364A</gtr:id><gtr:name>Joseph Fourier University</gtr:name><gtr:address><gtr:line1>CS40700</gtr:line1><gtr:postCode>F-38058</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8113FC13-FDEA-470A-A0BC-216AF34C1421"><gtr:id>8113FC13-FDEA-470A-A0BC-216AF34C1421</gtr:id><gtr:firstName>Ioannis</gtr:firstName><gtr:otherNames>Jiannis</gtr:otherNames><gtr:surname>Ragoussis</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1E2D89E7-4F85-4BE0-9DBD-A5463A7AE7A1"><gtr:id>1E2D89E7-4F85-4BE0-9DBD-A5463A7AE7A1</gtr:id><gtr:firstName>Irina</gtr:firstName><gtr:surname>Udalova</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0700818"><gtr:id>913F1131-7258-4F18-B91A-43628FC6CB3E</gtr:id><gtr:title>SYSTEMATIC QUANTITATIVE ANALYSIS OF NF-kappaB CO-ACTIVATORS</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700818</gtr:grantReference><gtr:abstractText>Inflammation is a normal physiological response to infection and injury, but can lead to extensive tissue damage and disability when elicited in excess. Pathological consequences of sustained inflammatory response include variety of autoimmune diseases, such as rheumatoid arthritis, Crohn s disease, ankylosing spondylitis and multiple sclerosis. A sustained inflammatory response is often linked to the break down in regulation of production of inflammatory molecules. In a normal self-resolving body response to infection or injury inflammatory molecules are produced for a defined period of time, while in chronic autoimmune conditions their production is prolonged. 
The production of many inflammatory molecules is controlled by a key family of regulatory proteins called NF-kappaB. Ways to modulate levels of these transcription factors and restore a normal cytokine balance are considered to be of a potential therapeutic importance. But NF-kappaB does not function in isolation. Many of the NF-kappaB dependent immune genes are also co-regulated by other ubiquitous transcription factors, including the IRF (interferon regulatory factor) family of transcription factors consisting of nine proteins. Which IRF proteins are able to synergise with NF-kappaB to regulate gene expression, and how this co-regulation is dependent on the sequence of genomic elements attracting these factors is the subject of this investigation. 
Understanding the basic elements underlying successful inflammatory response is important for designing targeted strategies for suppressing inflammation while preserving signals required for host defence. It will also help scientists to better understand why humans have so many families of ostensibly similar proteins and what specific functions they hold.
The research will be carried out by two groups: of Dr Irina Udalova at the Kennedy Institute of Rheumatology, Imperial College, and of Dr Ioannis Ragoussis at the Wellcome Trust Centre for Human Genetics, Oxford University. It will be laboratory based and will use novel genomic techniques and computational methods. The proposed novel techniques will replace the use of animals in research. Results generated in this study will be communicated through peer-reviewed scientific journals and through annual reports from respective Institutes and presented at scientific meetings.</gtr:abstractText><gtr:technicalSummary>IRF transcription factors have recently emerged as widespread cofactors of NF-kappaB, the key regulator of gene expression in inflammation. The fundamental goal of this proposal is to accurately and quantitatively annotate the minimal genomic elements that drive inflammatory response via co-recruitment of NF-kappaB and IRF transcription factors. We propose to systematically define in vitro binding specificities of various IRF dimers and to test how altering IRF-DNA interactions in vivo affects the expression of inflammatory genes in human macrophages exposed to bacterial products. The project builds on our existing expertise and recently developed genomic approaches, e.g. the protein-DNA arrays. It develops new ways for studying transcriptional gene regulation, such as the use of viruses for in situ manipulation of the chromatin in human cells, and will generate new reagents for quantitative analysis of cellular responses available to the scientific community. The mechanistic understanding of inflammatory gene control will provide an alternative path for the development of targeted therapeutic strategies for treating immune disorders.

The project is in conjunction with the MRC NIA award to Dr Udalova and solidifies the basis for her long term goal of trying to identify the molecular mechanisms that ensure successful inflammatory response. It promotes a longstanding successful collaboration between the two applicants. The promoter specific modules of NF-kappaB and IRF binding elements computationally identified during the course of this project will form a framework for future experimental studies of coordinated gene regulation in inflammation.</gtr:technicalSummary><gtr:fund><gtr:end>2010-02-28</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>424514</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs><gtr:artisticAndCreativeProductOutput><gtr:description>&amp;quot;Scientists at work&amp;quot; photo exhibition in the local gallery</gtr:description><gtr:id>F2B14D92-40F4-4A6B-8B1C-21C0ABE35C55</gtr:id><gtr:impact>Members of the group organising a photo club and taking monthly photos of interest. The topic &amp;quot;Scientists at work&amp;quot; was presented at the local gallery in London</gtr:impact><gtr:title>Photo exhibition</gtr:title><gtr:type>Artwork</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput></gtr:artisticAndCreativeProductOutputs><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Joseph Fourier University</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>The Albert Boniot Institute</gtr:department><gtr:description>SD</gtr:description><gtr:id>744D7D1C-5876-4221-9683-C45C20AFB2B2</gtr:id><gtr:impact>EU FP7 Model-In grant;
Extensive characterization of NF-?B binding uncovers non-canonical motifs and advances the interpretation of genetic functional traits.
Wong D, Teixeira A, Oikonomopoulos S, Humburg P, Lone IN, Saliba D, Siggers T, Bulyk M, Angelov D, Dimitrov S, Udalova IA, Ragoussis J.
Genome Biol. 2011 Jul 29;12(7):R70</gtr:impact><gtr:partnerContribution>analysis of TF-FNA interactions at a signle base resolution</gtr:partnerContribution><gtr:piContribution>provising selection of sequences for further analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>MB</gtr:description><gtr:id>206EA2A7-6412-45CD-BF5B-B70B8CA54D76</gtr:id><gtr:impact>Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-?B family DNA binding.
Siggers T, Chang AB, Teixeira A, Wong D, Williams KJ, Ahmed B, Ragoussis J, Udalova IA, Smale ST, Bulyk ML.
Nat Immunol. 2011 Nov 20;13(1):95-102.</gtr:impact><gtr:partnerContribution>access to the data</gtr:partnerContribution><gtr:piContribution>access to the data, providing with reagents</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>INTAS genomics and proteomics workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DEDA6410-1931-4B8B-9567-DE9D152EAF79</gtr:id><gtr:impact>presentation &amp;quot;Quantitative analysis of protein-DNA interactions: application to functional genomics&amp;quot;

education of students and public in Ukraine</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio and newspapers interviews</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>22E0160E-135A-4191-A989-4B2161C7E4A3</gtr:id><gtr:impact>press releases on our discovery of the master regulation of mph polarization

external visibility, public education</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Aggressive Lymphoma symposium</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>10C3379D-E477-4332-8AF9-9549EB56F90C</gtr:id><gtr:impact>&amp;quot;Functional effects of genetic polymorphisms: quantitative analysis of TF-DNA interactions&amp;quot; 30 min presentation at Aggressive Lymphoma symposium (Gottingen, Germany)

education of medical doctors</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>332796</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CO-REGULATION OF MACROPHAGE INFLAMMATORY PHENOTYPE BY IRF5 AND RELA</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>113B5D4B-AA77-40FA-9B69-3418B6DF4B89</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Can IRF5-expressing pro-inflammatory macrophages control allergic inflammation?</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>American Asthma Foundation</gtr:fundingOrg><gtr:id>CE5FE9B6-C9AF-4FED-80DA-E215D29B2816</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>This invention relates to modulating the immune system, and in particular to methods for modulating the immune system to treat disease. The invention further relates to methods for identifying agents that modulate the immune system to treat disease</gtr:description><gtr:id>975BE4F9-BB88-4A0E-9CAA-31B403DFF056</gtr:id><gtr:impact>potential industrial collaborations</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>WO2012093258</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>IRF5 in macrophage differentiation</gtr:title><gtr:yearProtectionGranted>2011</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>DNA vectors encoding cDNAs of various members of the Interferon Regulatory Factor family</gtr:description><gtr:id>3F0F8C8F-18ED-4792-B098-3DC7CED8718A</gtr:id><gtr:impact>allow to proceed with the DNA binding analysis and useful for functional studies of inflammatory gene expression: Thomas Krausgruber, David Saliba, Grigory Ryzhakov, Alessandra Lanfrancotti, Katrina Blazek, Irina A Udalova &amp;quot;IRF5 promotes sustained TNF production by human dendritic cells via two independent mechanisms&amp;quot; (submitted)</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>IRF expression constructs</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>quantitative data describing binding preferences of the IRF factors to housands of DNA sequences</gtr:description><gtr:id>6C786E97-1448-4B06-BAA7-AF5E8ABFB2B1</gtr:id><gtr:impact>extremely valuable for teasing out whole genome ChIP data and understanding transcriptional regulation of genes</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>IRF binding specificities</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>novel method for analysis of protein-DNA interactions</gtr:description><gtr:id>136F3F7B-3160-4A0A-B89A-D587871F1F62</gtr:id><gtr:impact>potentially better, faster, cheaper way of profiling binding specificities of transcription factors - multiple usage</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>EMSA-Seq</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/51BA9C97-ABD0-4593-8066-780011C18CAF"><gtr:id>51BA9C97-ABD0-4593-8066-780011C18CAF</gtr:id><gtr:title>IRF5:RelA interaction targets inflammatory genes in macrophages.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f2ad680215b87820a3b0656dd1546c52"><gtr:id>f2ad680215b87820a3b0656dd1546c52</gtr:id><gtr:otherNames>Saliba DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DC536F4B-24BC-4548-A9AE-8AC9334A8717"><gtr:id>DC536F4B-24BC-4548-A9AE-8AC9334A8717</gtr:id><gtr:title>Accuracy and reproducibility of protein-DNA microarray technology.</gtr:title><gtr:parentPublicationTitle>Advances in biochemical engineering/biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f51c7b764f2d48fd102a21e4374a14d1"><gtr:id>f51c7b764f2d48fd102a21e4374a14d1</gtr:id><gtr:otherNames>Field S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0724-6145</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/61D08F6B-15DA-4BCC-B611-C10C7DDB19F5"><gtr:id>61D08F6B-15DA-4BCC-B611-C10C7DDB19F5</gtr:id><gtr:title>IRF5 is required for late-phase TNF secretion by human dendritic cells.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2bb9087393698e862100990fefa91b4c"><gtr:id>2bb9087393698e862100990fefa91b4c</gtr:id><gtr:otherNames>Krausgruber T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B5AD1157-0382-4806-B586-1FFC38DD4033"><gtr:id>B5AD1157-0382-4806-B586-1FFC38DD4033</gtr:id><gtr:title>Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-?B family DNA binding.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/943fb9a48dc71d0e1469e86957fa20db"><gtr:id>943fb9a48dc71d0e1469e86957fa20db</gtr:id><gtr:otherNames>Siggers T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9C2A6A82-CCC9-4394-A978-4C07CEAB4979"><gtr:id>9C2A6A82-CCC9-4394-A978-4C07CEAB4979</gtr:id><gtr:title>FOXO3 as a new IKK-e-controlled check-point of regulation of IFN-? expression.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/86d5eb97ec909340dfa19b4c01320251"><gtr:id>86d5eb97ec909340dfa19b4c01320251</gtr:id><gtr:otherNames>Luron L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9304A491-E061-4CEF-B830-8C51BD3C27F4"><gtr:id>9304A491-E061-4CEF-B830-8C51BD3C27F4</gtr:id><gtr:title>Extensive characterization of NF-?B binding uncovers non-canonical motifs and advances the interpretation of genetic functional traits.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/44a66375eed4d8cabe4e39d3eee1527c"><gtr:id>44a66375eed4d8cabe4e39d3eee1527c</gtr:id><gtr:otherNames>Wong D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CE028963-87A5-4B0D-A530-84D22738A882"><gtr:id>CE028963-87A5-4B0D-A530-84D22738A882</gtr:id><gtr:title>IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2bb9087393698e862100990fefa91b4c"><gtr:id>2bb9087393698e862100990fefa91b4c</gtr:id><gtr:otherNames>Krausgruber T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4269D9B1-78B2-4F16-89F2-5D31C3E6D189"><gtr:id>4269D9B1-78B2-4F16-89F2-5D31C3E6D189</gtr:id><gtr:title>Cross-species analysis reveals evolving and conserved features of the nuclear factor ?B (NF-?B) proteins.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b1d84a4833493a5f2de6c0e6f9c85b75"><gtr:id>b1d84a4833493a5f2de6c0e6f9c85b75</gtr:id><gtr:otherNames>Ryzhakov G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700818</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>